| [1] Ishino Y, Shinagawa H, Makino K, et al. Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product. Journal of Bacteriology, 1987, 169(12): 5429-5433.
[2] Wei C, Liu J, Yu Z, et al. TALEN or Cas9-rapid, efficient and specific choices for genome modifications. Journal of Genetics and Genomics, 2013, 40(6): 281-289.
[3] Jansen R, Embden J, Gaastra W, et al. Identification of genes that are associated with DNA repeats in prokaryotes. Molecular Microbiology, 2002, 43(6): 1565-1575.
[4] Pourcel C, Salvignol G, Vergnaud G. CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies. Microbiology, 2005, 151(3): 653-663.
[5] Bolotin A, Quinquis B, Sorokin A, et al. Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin. Microbiology, 2005, 151(8): 2551-2561.
[6] Mojica F J, García-Martínez J, Soria E. Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements. Journal of Molecular Evolution, 2005, 60(2): 174-182.
[7] Quiberoni A, Moineau S, Rousseau G M, et al. Streptococcus thermophilus bacteriophages. International Dairy Journal, 2010, 20(10): 657-664.
[8] Horvath P, Romero D A, Coûté-Monvoisin A C, et al. Diversity, activity, and evolution of CRISPR loci in Streptococcus thermophilus. Journal of Bacteriology, 2008, 190(4): 1401-1412.
[9] Horvath P, Coûté-Monvoisin A C, Romero D A, et al. Comparative analysis of CRISPR loci in lactic acid bacteria genomes. International Journal of Food Microbiology, 2009, 131(1): 62-70.
[10] Jinek M, Chylinski K, Fonfara I, et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science, 2012, 337(6096): 816-821.
[11] Gasiunas G, Barrangou R, Horvath P, et al. Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proceedings of the National Academy of Sciences, 2012, 109(39): E2579-E2586.
[12] Cong L, Ran F A, Cox D, et al. Multiplex genome engineering using CRISPR/Cas systems. Science, 2013, 339(6121): 819-823.
[13] Mali P, Yang L, Esvelt K M, et al. RNA-guided human genome engineering via Cas9. Science, 2013, 339(6121): 823-826.
[14] Sander J D, Joung J K. CRISPR-Cas systems for editing, regulating and targeting genomes. Nature Biotechnology, 2014, 32(4): 347-355.
[15] Karginov F V, Hannon G J. The CRISPR system: small RNA-guided defense in bacteria and archaea. Molecular Cell, 2010, 37(1): 7-19.
[16] Doudna J A, Charpentier E. The new frontier of genome engineering with CRISPR-Cas9. Science, 2014, 346(6213): 1258096.
[17] Westra E R, Swarts D C, Staals R H, et al. The CRISPRs, they are a-changin': how prokaryotes generate adaptive immunity. Annual Review of Genetics, 2012, 46: 311-339.
[18] Jinek M, Jiang F, Taylor D W, et al. Structures of Cas9 endonucleases reveal RNA-mediated conformational activation. Science, 2014, 343(6176): 1247997.
[19] Deveau H, Barrangou R, Garneau J E, et al. Phage response to CRISPR-encoded resistance in Streptococcus thermophilus. Journal of Bacteriology, 2008, 190(4): 1390-1400.
[20] Nishimasu H, Ran F A, Hsu P D, et al. Crystal structure of Cas9 in complex with guide RNA and target DNA. Cell, 2014, 156(5): 935-949.
[21] Cho S W, Kim S, Kim J M, et al. Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nature Biotechnology, 2013, 31(3): 230-232.
[22] Sternberg S H, Redding S, Jinek M, et al. DNA interrogation by the CRISPR RNA-guided endonuclease Cas9. Nature, 2014, 507(7490): 62-67.
[23] Zhu S, Rong Z, Lu X, et al. Gene targeting via homologous recombination in monkey embryonic stem cells using CRISPR/Cas9 system. Stem Cells and Development, 2015, 4(10):1147-1149.
[24] Bauer D E, Canver M C, Orkin S H. Generation of genomic deletions in mammalian cell Lines via CRISPR/Cas9. Journal of Visualized Experiments, 2015, (95): e52118-e52118.
[25] Osborn M J, Gabriel R, Webber B R, et al. Fanconi anemia gene editing by the CRISPR/Cas9 system. Human Gene Therapy, 2014, 26(2):114-126.
[26] Mandal P K, Ferreira L M, Collins R, et al. Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR/Cas9. Cell Stem Cell, 2014, 15(5): 643-652.
[27] Belhaj K. Editing plant genomes with CRISPR/Cas9. Open Access Overview.[2014-11-29]. http://www.sciencedirect.com/science/article/pii/S0958166914001943.
[28] Fan Z, Li W, Lee SR et al. Efficient gene targeting in golden Syrian hamsters by the CRISPR/Cas9 system. PLoS One, 2014, 9(10): e109755.
[29] Kimura Y. Efficient generation of knock-in transgenic zebrafish carrying reporter/driver genes by CRISPR/Cas9-mediated genome engineering. Open Access Overview.[2014-10-8]. http://www.nature.com/articles/srep06545?WT.ec_id=SREP-631-20141014.
[30] Smith C, Gore A, Yan W, et al. Whole-genome sequencing analysis reveals high specificity of CRISPR/Cas9 and TALEN-based genome editing in human iPSCs. Cell Stem Cell, 2014, 15(1): 12-13.
[31] Fu Y, Foden J A, Khayter C, et al. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nature Biotechnology, 2013, 31(9): 822-826.
[32] Ran F A, Hsu P D, Lin C Y, et al. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell, 2013, 154(6): 1380-1389.
[33] Pattanayak V, Lin S, Guilinger J P, et al. High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Nature Biotechnology, 2013, 31(9): 839-843.
[34] Shen B, Zhang W, Zhang J, et al. Efficient genome modification by CRISPR-Cas9 nickase with minimal off-target effects. Nature Methods, 2014, 11(4): 399-402.
[35] Duan J, Lu G, Xie Z, et al. Genome-wide identification of CRISPR/Cas9 off-targets in human genome. Cell Research, 2014, 24(8): 1009-1012.
[36] Veres A, Gosis B S, Ding Q, et al. Low incidence of off-target mutations in individual CRISPR-Cas9 and TALEN targeted human stem cell clones detected by whole-genome sequencing. Cell Stem Cell, 2014, 15(1): 27-30.
[37] Suzuki K, Yu C, Qu J, et al. Targeted gene correction minimally impacts whole-genome mutational load in human-disease-specific induced pluripotent stem cell clones. Cell Stem Cell, 2014, 15(1): 31-36.
[38] Cradick T J, Fine E J, Antico C J, et al. CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activity. Nucleic Acids Research, 2013,43(18):1093.
[39] Bell C C, Magor G W, Gillinder K R, et al. A high-throughput screening strategy for detecting CRISPR-Cas9 induced mutations using next-generation sequencing. BMC Genomics, 2014, 15(1): 1002.
[40] Zhang H, Zhang J, Wei P, et al. The CRISPR/Cas9 system produces specific and homozygous targeted gene editing in rice in one generation. Plant Biotechnology Journal, 2014, 12(6): 797-807.
[41] Yu C, Liu Y, Ma T, et al. Small molecules enhance CRISPR genome editing in pluripotent stem cells. Cell Stem Cell, 2015, 16(2): 142-147.
[42] Crosetto N, Mitra A, Silva M J, et al. Nucleotide-resolution DNA double-strand break mapping by next-generation sequencing. Nature Methods, 2013, 10(4): 361-365.
[43] Tsai S Q, Zheng Z, Nguyen N T, et al. GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nature Biotechnology, 2015,33(2):187-197.
[44] Larson M H, Gilbert L A, Wang X, et al. CRISPR interference (CRISPRi) for sequence-specific control of gene expression. Nature Protocols, 2013, 8(11): 2180-2196.
[45] Perez-Pinera P, Kocak D D, Vockley C M, et al. RNA-guided gene activation by CRISPR-Cas9-based transcription factors. Nature Methods, 2013, 10(10): 973-976.
[46] Maeder M L, Linder S J, Cascio V M, et al. CRISPR RNA-guided activation of endogenous human genes. Nature Methods, 2013, 10(10): 977-979.
[47] Qi L S, Larson M H, Gilbert L A, et al. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell, 2013, 152(5): 1173-1183.
[48] Gilbert L A, Larson M H, Morsut L, et al. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell, 2013, 154(2): 442-451.
[49] Zhou Y, Zhu S, Cai C et al. High-throughput screening of a CRISPR/Cas9 library for functional genomics in human cells. Nature, 2014, 509(7501): 487-491.
[50] Tanenbaum M E, Gilbert L A, Qi L S, et al. A protein-tagging system for signal amplification in gene expression and fluorescence imaging. Cell, 2014, 159(3): 635-646.
[51] Gilbert L A, Horlbeck M A, Adamson B, et al. Genome-scale CRISPR-mediated control of gene repression and activation. Cell, 2014, 159(3): 647-661.
[52] Puente XS, Pinyol M, Quesada V, et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature, 2011, 475(7354): 101-105.
[53] Berger M F, Hodis E, Heffernan T P, et al. Melanoma genome sequencing reveals frequent PREX2 mutations. Nature, 2012, 485(7399): 502-506.
[54] Quesada V, Conde L, Villamor N, et al. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nature Genetics, 2012, 44(1): 47-52.
[55] Savitskaya E, Semenova E, Dedkov V, et al. High-throughput analysis of type IE CRISPR/Cas spacer acquisition in E. coli. RNA Biology, 2013, 10(5): 716-725.
[56] Richter H, Zoephel J, Schermuly J, et al. Characterization of CRISPR RNA processing in Clostridium thermocellum and Methanococcus maripaludis. Nucleic Acids Research, 2012, 40(19): 9887-9896. |
